Trial NCT02867280

View at ClinicalTrials.gov 
Org. Study IDs: Sorafenib-MVI

Last trial update was posted on 2020-02-11

MeSH Interventions

Sorafenib

MeSH Conditions

Carcinoma Carcinoma, Hepatocellular Recurrence

Other Conditions

Hepatocellular Carcinoma

Stopping Reasons

Midterm analysis showed negative results.

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID